Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate

Benjamin Greenberg, Steven Hall, Michael Grabner, Sanjeev Balu, Xian Zhang, Daniel Kantor

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate'. Together they form a unique fingerprint.

Medicine & Life Sciences